239 related articles for article (PubMed ID: 17587829)
1. PRL-3: a metastasis-associated phosphatase in search of a function.
Bessette DC; Wong PC; Pallen CJ
Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829
[TBL] [Abstract][Full Text] [Related]
2. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
3. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.
Peng L; Jin G; Wang L; Guo J; Meng L; Shou C
Biochem Biophys Res Commun; 2006 Mar; 342(1):179-83. PubMed ID: 16472776
[TBL] [Abstract][Full Text] [Related]
4. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis.
Zeng Q; Dong JM; Guo K; Li J; Tan HX; Koh V; Pallen CJ; Manser E; Hong W
Cancer Res; 2003 Jun; 63(11):2716-22. PubMed ID: 12782572
[TBL] [Abstract][Full Text] [Related]
5. PRL-3 expression in metastatic cancers.
Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
[TBL] [Abstract][Full Text] [Related]
6. A phosphatase associated with metastasis of colorectal cancer.
Saha S; Bardelli A; Buckhaults P; Velculescu VE; Rago C; St Croix B; Romans KE; Choti MA; Lengauer C; Kinzler KW; Vogelstein B
Science; 2001 Nov; 294(5545):1343-6. PubMed ID: 11598267
[TBL] [Abstract][Full Text] [Related]
7. PRL-3 phosphatase and cancer metastasis.
Al-Aidaroos AQ; Zeng Q
J Cell Biochem; 2010 Dec; 111(5):1087-98. PubMed ID: 21053359
[TBL] [Abstract][Full Text] [Related]
8. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells.
Wu X; Zeng H; Zhang X; Zhao Y; Sha H; Ge X; Zhang M; Gao X; Xu Q
Am J Pathol; 2004 Jun; 164(6):2039-54. PubMed ID: 15161639
[TBL] [Abstract][Full Text] [Related]
9. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
[TBL] [Abstract][Full Text] [Related]
10. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis.
Li Z; Zhan W; Wang Z; Zhu B; He Y; Peng J; Cai S; Ma J
Biochem Biophys Res Commun; 2006 Sep; 348(1):229-37. PubMed ID: 16875667
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer.
Yamashita S; Masuda Y; Matsumoto K; Okumura Y; Matsuzaki H; Kurizaki T; Haga Y; Katafuchi S; Murayama T; Ikei S; Kawahara K
Ann Thorac Cardiovasc Surg; 2007 Aug; 13(4):236-9. PubMed ID: 17717498
[TBL] [Abstract][Full Text] [Related]
13. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
14. PRL-3 phosphatase is implicated in ovarian cancer growth.
Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
[TBL] [Abstract][Full Text] [Related]
15. Cancer research. New insights into metastasis.
Marx J
Science; 2001 Oct; 294(5541):281-2. PubMed ID: 11598274
[No Abstract] [Full Text] [Related]
16. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.
Matter WF; Estridge T; Zhang C; Belagaje R; Stancato L; Dixon J; Johnson B; Bloem L; Pickard T; Donaghue M; Acton S; Jeyaseelan R; Kadambi V; Vlahos CJ
Biochem Biophys Res Commun; 2001 May; 283(5):1061-8. PubMed ID: 11355880
[TBL] [Abstract][Full Text] [Related]
17. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
18. PRL PTPs: mediators and markers of cancer progression.
Bessette DC; Qiu D; Pallen CJ
Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
[TBL] [Abstract][Full Text] [Related]
19. Requirement of phosphatase of regenerating liver-3 for the nucleolar localization of nucleolin during the progression of colorectal carcinoma.
Semba S; Mizuuchi E; Yokozaki H
Cancer Sci; 2010 Oct; 101(10):2254-61. PubMed ID: 20860603
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
Zhao WB; Li Y; Liu X; Zhang LY; Wang X
Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
